Plasma Cell Neoplasms

Mar 13, 2017 by in ONCOLOGY Comments Off on Plasma Cell Neoplasms

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 31 Plasma Cell Neoplasms Ravi Vij and Jesse Keller QUESTIONS Each of the numbered items below is followed by lettered answers. Select the…

read more

Immunosuppression-Related Malignancies

Mar 13, 2017 by in ONCOLOGY Comments Off on Immunosuppression-Related Malignancies

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 32 Immunosuppression-Related Malignancies Lee Ratner QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer that…

read more

Chronic Leukemias

Mar 13, 2017 by in ONCOLOGY Comments Off on Chronic Leukemias

One of the most prognostically significant landmarks is achieving CCyR at 12 months and many other parameters are based on the likelihood of obtaining this response. For example, for patients…

read more

Acute Leukemias

Mar 13, 2017 by in ONCOLOGY Comments Off on Acute Leukemias

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 29 Acute Leukemias Amanda F. Cashen QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer…

read more

Lymphomas

Mar 13, 2017 by in ONCOLOGY Comments Off on Lymphomas

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 28 Lymphomas Nina Wagner-Johnston and Dilan Patel QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered…

read more

Cancer of the Skin and Melanoma

Mar 13, 2017 by in ONCOLOGY Comments Off on Cancer of the Skin and Melanoma

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 27 Cancer of the Skin and Melanoma Gerald P. Linette QUESTIONS Each of the numbered items below is followed by lettered answers. Select…

read more

Sarcomas

Mar 13, 2017 by in ONCOLOGY Comments Off on Sarcomas

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 26 Sarcomas Brian A. Van Tine and Angela C. Hirbe QUESTIONS Each of the numbered items below is followed by lettered answers. Select…

read more

Cancers of the Central Nervous System

Mar 13, 2017 by in ONCOLOGY Comments Off on Cancers of the Central Nervous System

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 25 Cancers of the Central Nervous System Tanner M. Johanns, Jian Li Campian and George Ansstas QUESTIONS Each of the numbered items below…

read more

Breast Cancer

Mar 13, 2017 by in ONCOLOGY Comments Off on Breast Cancer

    Incorporation of gemcitabine into adjuvant anthracyclines- and taxanes-based chemotherapy does not improve efficacy. Question 24.21 The answer is A. Preexisting cardiac disease, age >65 years, anthracycline-based chemotherapy, borderline left ventricular…

read more

Ovarian Cancers

Mar 13, 2017 by in ONCOLOGY Comments Off on Ovarian Cancers

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 23 Ovarian Cancers David G. Mutch QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer…

read more
Get Clinical Tree app for offline access